Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 4, 2014, Pages 2006-2012

  Espinel Ingroff, A ^a   Pfaller, M A ^b,c   Bustamante, B ^d   Canton, E ^e   Fothergill, A ^f   Fuller, J ^g   Gonzalez, G M ^h   Lass Florl C ⁱ   Lockhart, S R ^j   Martin Mazuelos, E ^k   Meis, J F ^l,m   Melhem, M S C ⁿ   Ostrosky Zeichner, L ^o   Pelaez, T ^p   Szeszs, M W ⁿ   St Germain, G ^q   Bonfietti, L X ⁿ   Guarro, J ^r   Turnidge, J ^s  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b JMI LABORATORIES   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g UNIVERSITY OF ALBERTA   (Canada)

^h UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

ⁱ INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^j CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^k HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^l CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^m RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

ⁿ INSTITUTO ADOLFO LUTZ   (Brazil)

^o UNIVERSITY OF TEXAS   (United States)

^p HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^q INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^r INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^s UNIVERSITY OF ADELAIDE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BRAZIL; BROTH DILUTION; CANADA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; CYBERLINDNERA JADINII; EUROPE; FUNGAL DETECTION; FUNGUS ISOLATION; MEXICO; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERU; PRIORITY JOURNAL; UNITED STATES; UPREGULATION; WILD TYPE;

ANTIFUNGAL AGENTS; CANDIDA; FLUCONAZOLE; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; TRIAZOLES;

EID: 84896913990     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02615-13     Document Type: Article

References (41)

1. Messer SA, Jones RN, Fritsche TR. 2006. International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003). J. Clin. Microbiol. 44:1782-1787. http://dx.doi.org/10.1128/JCM.44.5.1782-1787.2006. (Pubitemid 43726269)
2. Costa-de-Oliveira S, Pina-Vaz C, Mendonca D, Goncalves Rodrigues A. 2008. A first Portuguese epidemiological survey of fungaemia in a university hospital. Eur. J. Clin. Microbiol. Infect. Dis. 27:365-374. http://dx.doi.org/ 10.1007/s10096-007-0448-4.
3. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr, Calandra TF, Edwards JE, Filler SG, Fischer JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535. http://dx.doi.org/10.1086/596757.
4. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Flörl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ, ESCMID Fungal Infection Study Group. 2012. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin. Microbiol. Infect. 18:19-37. http://dx.doi.org/10.1111/1469- 0691.12039.
5. Espinel-Ingroff A, Pfaller M, Canton E, Peman J. 2010. Emerging resistance to azoles and echinocandins: clinical relevance and laboratory detection. Curr. Fungal Infect. Rep. 4:186-195. http://dx.doi.org/10.1007/ s12281-010-0026-6.
6. Chau AS, Mendrick CA, Sabatelli FJ, Loebenberg D, McNicholas PM. 2004. Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles. Antimicrob. Agents Chemother. 48:2124-2131. http://dx.doi.org/10.1128/AAC.48.6.2124-2131.2004. (Pubitemid 38691608)
7. Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J. 1999. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob. Agents Chemother. 43:2753-2765. (Pubitemid 29519560)
8. Silva AP, Miranda IM, Guida A, Synnott J, Rocha R, Silva R, Amorim A, Pina-Vaz C, Butler G, Rodrigues AG. 2011. Transcriptional profiling of azole-resistant Candida parapsilosis strains. Antimicrob. Agents Chemother. 55:3546-3556. http://dx.doi.org/10.1128/AAC.01127-10.
9. Vandeputte P, Larcher G, Berges T, Renier G, Chabasse D, Bouchara J-P. 2005. Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob. Agents Chemother. 49:4608-4615. http://dx.doi.org/10. 1128/AAC.49.11.4608-4615.2005. (Pubitemid 41552590)
10. Moran GP, Sanglard D, Donnelly SM, Shanley DB, Sullivan DJ, Coleman DC. 1998. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42:1819-1830. (Pubitemid 28311586)
11. Orozco AS, Higginbotham LM, Hitchcock CA, Parkinson T, Falconer D, Ibrahim AS, Ghannoum MA, Filler SG. 1998. Mechanism of fluconazole resistance in Candida krusei. Antimicrob. Agents Chemother. 42:2645-2649. (Pubitemid 28462908)
12. Pfaller MA, Diekema DJ. 2012. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J. Clin. Microbiol. 50:2846-2856. http://dx.doi.org/10.1128/JCM.00937-12.
13. Clinical and Laboratory Standards Institute. 2012. M27-S4. Reference method for broth dilution antifungal susceptibility testing of yeasts, 4th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
14. Kahlmeter G, Brown DF, Goldstein FW, MacGowan AP, Mouton JW, Osterlund A, Rodloff A, Steinbakk M, Urbaskova P, Vatopoulos A. 2003. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J. Antimicrob. Chemother. 52:145-148. http://dx.doi.org/10.1093/jac/dkg312. (Pubitemid 36986868)
15. Simjee S, Silley P, Werling HO, Bywater R. 2008. Potential confusion regarding the term "resistance" in epidemiological surveys. J. Antimicrob. Chemother. 61:228-229. http://dx.doi.org/10.1093/jac/dkm423.
16. Turnidge J, Patterson DL. 2007. Setting and revising antibacterial susceptibility breakpoints. Clin. Microbiol. Rev. 20:391-408. http://dx.doi.org/10.1128/CMR.00047-06. (Pubitemid 47175010)
17. Clinical and Laboratory Standards Institute. 2008. M27-A3. Reference method for broth dilution antifungal susceptibility testing of yeasts, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
18. Xiao L, Madison V, Chau AS, Loebenberg D, Palermo RF, McNicholas PM. 2004. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14-alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob. Agents Chemother. 48:568-574. http://dx.doi.org/10.1128/AAC.48.2.568-574.2004. (Pubitemid 38141718)
19. MacCallum DM, Coste A, Ischer F, Jacobsen MD, Odds FC, Sanglard D. 2010. Genetic sissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection. Antimicrob. Agents Chemother. 54:1476-11483. http://dx.doi.org/10.1128/AAC.01645-09.
20. Pinjon E, Moran GP, Jackson CJ, Kelly SL, Sanglard D, Coleman DC, Sullivan DJ. 2003. Molecular mechanisms of itraconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 47:2424-2437. http://dx.doi.org/10. 1128/AAC.47.8.2424-2437.2003. (Pubitemid 36919440)
21. Pinjon E, Jackson CJ, Kelly SL, Sanglard D, Moran G, Sullivan DJ. 2005. Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression. Antimicrob. Agents Chemother. 49:1312-1318. http://dx.doi.org/10.1128/AAC.49.4.1312-1318.2005. (Pubitemid 40463353)
22. Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G. 2005. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob. Agents Chemother. 49:668-679. http://dx.doi.org/10.1128/AAC.49.2.668-679.2005. (Pubitemid 40175679)
23. Borst A, Raimer MT, Warnock DW, Morrison CJ, Arthington-Skaggs BA. 2005. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole. Antimicrob. Agents Chemother. 49:783-787. http://dx.doi.org/10.1128/AAC.49.2.783-787.2005. (Pubitemid 40175697)
24. Posteraro B, Tumbarello M, La Sorda M, Spanu T, Trecarichi EM, De Bernardis F, Scoppettuolo G, Sanguinetti M, Fadda G. 2006. Azole resistance of Candida glabrata in a case of recurrent fungemia. J. Clin. Microb. 44:3046-3047. http://dx.doi.org/10.1128/JCM.00526-06. (Pubitemid 44228619)
25. Ferrari S, Ischer F, Calabrese D, Posteraro B, Sanguinetti M, Fadda G, Rohde B, Bauser C, Bader O, Sanglard D. 2009. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog. 5:e1000268. http://dx.doi.org/10.1371/journal. ppat.1000268.
26. Forastiero A, Mesa-Arango AC, Alastruey-Izquierdo A, Alcazar-Fuoli L, Bernal Martinez L, Pelaez T, Lopez JF, Grimalt JO, Gomez-Lopez A, Cuesta I, Zaragoza O, Mellado E. 2013. Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications. Antimicrob. Agents Chemother. 57:4769-4781. http://dx.doi.org/10.1128/AAC.00477-13.
27. Howell SA, Hazen KC. 2011. Candida, Cryptococcus, and other yeasts of medical importance: mycology, p 1793-1821. In Versalovic J, Carroll KC, Jorgensen JH, Funke G, Landry ML, WarnockDW(ed), Manual of clinical microbiology, 10th ed, vol 2. ASM Press, Washington, DC.
28. Turnidge J, Kahmeter G, Kronvall G. 2006. Statistical characterization of bacterial wild-type MIC value distributions and determination of epidemiological cutoff values. Clin. Microbiol. Infect. 12:418-425. http://dx.doi.org/10.1111/j.1469-0691.2006.01377.x.
29. Espinel-Ingroff A, Cuenca-Estrella M, Canton E. 2013. CLSI and EUCAST: working together towards a harmonized method for antifungal susceptibility testing. Curr. Fungal Infect. Rep. 7:59-67. http://dx.doi.org/10.1007/s12281- 012-0125-7.
30. Espinel-Ingroff A, Chowdhary A, Gonzalez GM, Lass-Flörl C, Martin-Mazuelos E, Meis J, Pelaez T, Pfaller MA, Turnidge. 2013. J. Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method. Antimicrob. Agents Chemother. 57:3823-3828. http://dx.doi.org/10.1128/AAC.00636-13.
31. Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaez T, Pukinskas SRBS, St-Germain G, Szeszs MW, Turnidge J. 2013. Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob. Agents Chemother. 57:5836-5842. http://dx.doi.org/10.1128/AAC.01519-13.
32. Pfaller MA, Espinel-Ingroff A, Bustamante B, Canton E, Diekema DJ, Fothergill A, Fuller J, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Martin-Mazuelos E, Meis JF, Ostrosky-Zeichner L, Pelaez T, St-Germain G, Turnidge J. 2014. Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method. Antimicrob. Agents Chemother. 58:916-922. http://dx.doi.org/10.1128/AAC.02020-13.
33. Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P. 2008. Activity of voriconazole, itraconazole, fluconazole and amphotericin B against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies. Int. J. Antimicrob. Agents 32:511-514. http://dx.doi.org/10.1016/j.ijantimicag. 2008.05.023.
34. Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM. 2006. In vitro activity of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob. Agents Chemother. 50:2009-2015. http://dx.doi.org/10.1128/AAC.00163-06. (Pubitemid 43807519)
35. Pfaller MA, Messer SA, Gee S, Joly S, Pujol C, Sullivan DJ, Coleman DC, Soll DR. 1999. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J. Clin. Microbiol. 37:870-872. (Pubitemid 29091332)
36. Espinel-Ingroff A. 2003. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev. Iberoam. Micol. 20:121-136. (Pubitemid 38724618)
37. Guinea J, Sanchez-Somolinos M, Cuevas O, Pelaez T, Bouza E. 2006. Mechanism of fluconazole resistance mechanisms in Candida krusei: the contribution of efflux-pumps. Med. Mycol. 44:575-579. http://dx.doi.org/10.1080/ 13693780600561544.
38. Cantón E, Iñiguez C, Pemán J, Hervás D, Lopez-Hontangas JL, Pina-Vaz C, Camarena JJ, Campos-Herrero I, García-García I, García-Tapia AM, Guna R, Merino P, Pérez del Molino L, Rubio C, Suarez A, FUNGEMYCA Study Group. 2013. Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne method. J. Clin. Microbiol. 51:2691-2695. http://dx.doi.org/10.1128/JCM.01230-13.
39. Vanden Bossche H, Marichal P, Odds FC. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:393-400. http://dx.doi.org/10.1016/ 0966-842X(94)90618-1. (Pubitemid 24320452)
40. Katiyar SK, Edlind TD. 2001. Identification and expression of multidrug resistance related to ABC transporter genes in Candida krusei. Med. Mycol. 39:109-116. http://dx.doi.org/10.1080/mmy.39.1.109.116, http://dx.doi.org/10. 1080/714030988. (Pubitemid 32192925)
41. Arendrup MC, Cuenca-Estrella M, Donnelly JP, the European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing. 2011. EUCAST technical note on posaconazole. Clin. Microbiol. Infect. 17:E16-E17. http://dx.doi.org/10.1111/j.1469-0691.2011.03646.x.